2-Amino-5-chlor-3'-fluor-benzophenon | 784-39-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-Amino-5-chlor-3'-fluor-benzophenon
• 英文别名: (2-amino-5-chlorophenyl)(3-fluorophenyl)methanone；(2-amino-5-chlorophenyl)-(3-fluorophenyl)methanone
• CAS: 784-39-4
• 化学式: C₁₃H₉ClFNO
• 分子量: 249.672
• InChiKey: RIRNRSNOOZQYSI-UHFFFAOYSA-N

物化性质

• 熔点：
  90-91 °C
• 沸点：
  427.3±45.0 °C(Predicted)
• 密度：
  1.342±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  17
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  43.1
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-Amino-5-chlor-3'-fluor-benzophenon 在 potassium hydroxide 作用下， 以 乙醇 、 水 、 N,N-二甲基甲酰胺 为溶剂， 反应 0.88h， 生成 (E)-6-chloro-3-[3-(4-chlorophenyl)acryloyl]-4-(3-fluorophenyl)quinolin-2(1H)-one
  参考文献：
  名称：

  Structure–Activity Relationships and Pharmacophore Model of a Noncompetitive Pyrazoline Containing Class of GluN2C/GluN2D Selective Antagonists

  摘要：

  Here we describe the synthesis and structure-activity relationship for a class of pyrazoline-containing dihydroquinolone negative allosteric modulators of the NMDA receptor that show strong subunit selectivity for GluN2C- and GluN2D-containing receptors over GluN2A- and GluN2B-containing receptors. Several members of this class inhibit NMDA receptor responses in the nanomolar range and are more than 50-fold selective over GluN1/GluN2A and GluN1/GluN2B NMDA receptors, as well as AMPA, kainate, GABA, glycine, nicotinic, serotonin, and purinergic receptors. Analysis of the purified enantiomers of one of the more potent and selective compounds shows that the S-enantiomer is both more potent and more selective than the R-enantiomer. The S-enantiomer had an IC50 of 0.17-0.22 mu M at GluN2D- and GluN2C-containing receptors, respectively, and showed over 70-fold selectivity over other NMDA receptor subunits. The subunit selectivity of this class of compounds should be useful in defining the role of GluN2C- and GluN2D-containing receptors in specific brain circuits in both physiological and pathophysiological conditions.

  DOI：

  10.1021/jm400652r
• 作为产物：
  描述：

  5-氯靛红酸酐 在 正丁基锂 、 三乙胺 作用下， 以 四氢呋喃 、 乙醇 、 正己烷 为溶剂， 反应 2.17h， 生成 2-Amino-5-chlor-3'-fluor-benzophenon
  参考文献：
  名称：

  Structure–Activity Relationships and Pharmacophore Model of a Noncompetitive Pyrazoline Containing Class of GluN2C/GluN2D Selective Antagonists

  摘要：

  Here we describe the synthesis and structure-activity relationship for a class of pyrazoline-containing dihydroquinolone negative allosteric modulators of the NMDA receptor that show strong subunit selectivity for GluN2C- and GluN2D-containing receptors over GluN2A- and GluN2B-containing receptors. Several members of this class inhibit NMDA receptor responses in the nanomolar range and are more than 50-fold selective over GluN1/GluN2A and GluN1/GluN2B NMDA receptors, as well as AMPA, kainate, GABA, glycine, nicotinic, serotonin, and purinergic receptors. Analysis of the purified enantiomers of one of the more potent and selective compounds shows that the S-enantiomer is both more potent and more selective than the R-enantiomer. The S-enantiomer had an IC50 of 0.17-0.22 mu M at GluN2D- and GluN2C-containing receptors, respectively, and showed over 70-fold selectivity over other NMDA receptor subunits. The subunit selectivity of this class of compounds should be useful in defining the role of GluN2C- and GluN2D-containing receptors in specific brain circuits in both physiological and pathophysiological conditions.

  DOI：

  10.1021/jm400652r

文献信息

• Compounds and methods for inhibiting mitotic progression
  申请人：Claiborne F. Christopher

  公开号：US20050256102A1

  公开（公告）日：2005-11-17

  This invention relates to compounds and methods for the treatment of cancer. In particular, the invention provides compounds that inhibit Aurora kinase, pharmaceutical compositions comprising the compounds, and methods of using the compounds for the treatment of cancer.

  这项发明涉及用于治疗癌症的化合物和方法。具体而言，该发明提供了抑制枢纽激酶的化合物，包含这些化合物的药物组合物，以及利用这些化合物治疗癌症的方法。
• Trifluoroacetic Acid: An Efficient Catalyst for Paal-Knorr Pyrrole Synthesis and Its Deprotection
  作者：K. Narayanaswamy Venugopala、Renuka T. Prasanna、Bharti Odhav

  DOI：10.14233/ajchem.2013.15185

  日期：——

  In the present work, we demonstrated a simple and an efficient method for the condensation of substituted aryl/heteroaryl amines with acetonylacetone in the presence of trifluoro acetic acid to afford the corresponding 2,5-dimethyl-1-substitued pyrroles using Paal-Knorr synthesis in excellent yields. Trifluoroacetic acid was used under reflux condition for the deprotection of 2,5-dimethyl-1-substitued pyrroles to their corresponding substituted aryl/heteroaryl amines in moderate yields. 2,5-Dimethyl-1-substitued pyrrole were characterized by NMR and LC-MS. The yield of the compounds was found to be excellent.

  在本研究中，我们展示了一种简单有效的方法，通过在氟代乙酸的存在下，将取代的芳基/杂芳基胺与乙酰乙酮缩合，得到相应的2,5-二甲基-1-取代吡咯，采用Paal-Knorr合成法，收率极佳。氟代乙酸在回流条件下用于将2,5-二甲基-1-取代吡咯去保护为相应的取代芳基/杂芳基胺，收率为中等。2,5-二甲基-1-取代吡咯通过核磁共振（NMR）和液相色谱-质谱（LC-MS）进行了表征。发现化合物的收率非常好。
• One‐Pot Synthesis of 2‐Aminobenzophenones from 2‐Alkynyl Arylazides Catalyzed by Pd and Cu Precursors
  作者：Fan Yang、Shijie Xu、Hui Fan、Xuechun Zhao、Xiaoxiang Zhang

  DOI：10.1002/ejoc.202100772

  日期：2021.8.26

  A novel, one-pot, three-step synthetic method to prepare 2-aminobenzophenones from 2-alkynyl arylazides has been disclosed. This reaction is catalyzed by palladium to form 3-hydroxy-3-phenylindolin-2-ones, which is followed by hydrolysis of amide bonds and copper-catalyzed decarboxylation to generate 2-aminobenzophenones. The desired products are afforded in moderate to good yields under mild reaction

  公开了一种从 2-炔基芳基叠氮化物制备 2-氨基二苯甲酮的新型一锅三步合成方法。该反应由钯催化形成 3-羟基-3-苯基吲哚-2-酮，随后酰胺键水解和铜催化脱羧生成 2-氨基二苯甲酮。在温和的反应条件下以中等至良好的产率得到所需产物。
• Dihydroquinazolines as a Novel Class of Trypanosoma brucei Trypanothione Reductase Inhibitors: Discovery, Synthesis, and Characterization of their Binding Mode by Protein Crystallography
  作者：Stephen Patterson、Magnus S. Alphey、Deuan C. Jones、Emma J. Shanks、Ian P. Street、Julie A. Frearson、Paul G. Wyatt、Ian H. Gilbert、Alan H. Fairlamb

  DOI：10.1021/jm200312v

  日期：2011.10.13

  validated drug target in the parasite Trypanosoma brucei, the causative agent of human African trypanosomiasis. Here we report the discovery, synthesis, and development of a novel series of TryR inhibitors based on a 3,4-dihydroquinazoline scaffold. In addition, a high resolution crystal structure of TryR, alone and in complex with substrates and inhibitors from this series, is presented. This represents

  锥虫硫酮还原酶 (TryR) 是一种在寄生虫布氏锥虫中经过基因验证的药物靶点，人类非洲锥虫病的病原体。在这里，我们报告了基于 3,4-二氢喹唑啉支架的一系列新型 TryR 抑制剂的发现、合成和开发。此外，还展示了 TryR 的高分辨率晶体结构，单独以及与该系列的底物和抑制剂复合。这代表了非共价配体和这种酶之间的高分辨率复合物的第一份报告。结构研究表明，在配体结合后，酶会发生构象变化，产生一个新的亚袋，该亚袋被配体上的芳基占据。因此，抑制剂实际上在原本较大的、暴露于溶剂的活性位点内产生了它自己的小结合袋。TryR-配体结构随后用于指导抑制剂的合成，包括挑战诱导子口袋的类似物。这导致开发出对 TryR 和T. brucei寄生虫在全细胞测定中。
• COMPOUNDS AND METHODS FOR INHIBITING MITOTIC PROGRESSION
  申请人：Claiborne Christopher F.

  公开号：US20090299060A1

  公开（公告）日：2009-12-03

  This invention relates to compounds and methods for the treatment of cancer. In particular, the invention provides compounds that inhibit Aurora kinase, pharmaceutical compositions comprising the compounds, and methods of using the compounds for the treatment of cancer.

  本发明涉及化合物和治疗癌症的方法。具体来说，本发明提供抑制极化激酶的化合物，包含该化合物的制药组合物以及使用该化合物治疗癌症的方法。